Venera Kuci Emruli

Researcher
More filtering options
  1. 2019
  2. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia

    Papakonstantinou, N., Ntoufa, S., Tsagiopoulou, M., Moysiadis, T., Bhoi, S., Malousi, A., Psomopoulos, F., Mansouri, L., Laidou, S., Papazoglou, D., Gounari, M., Pasentsis, K., Plevova, K., Kuci-Emruli, V., Duran-Ferrer, M., Davis, Z., Ek, S., Rossi, D., Gaidano, G., Ritgen, M. & 11 othersOscier, D., Stavroyianni, N., Pospisilova, S., Davi, F., Ghia, P., Hadzidimitriou, A., Belessi, C., Martin-Subero, J. I., Pott, C., Rosenquist, R. & Stamatopoulos, K., 2019, In : International Journal of Cancer. 144, 11, p. 2695-2706

    Research output: Contribution to journalArticle

  3. 2018
  4. A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

    A. Ljungars, Mårtensson, L., Jenny Mattsson, Kovacek, M., Sundberg, A., Tornberg, U-C., B. Jansson, Persson, N., V. Kuci Emruli, S. Ek, M. Jerkeman, M. Hansson, G. Juliusson, M. Ohlin, Frendéus, B., Teige, I. & Mattsson, M., 2018 Dec 1, In : JCO Precision Oncology. 2, 1

    Research output: Contribution to journalArticle

  5. Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

    Freiburghaus, C., Venera Kuci Emruli, Johansson, A., Eskelund, C. W., Grønbæk, K., Roger Olsson, Fredrik Ek, Mats Jerkeman & Sara Ek, 2018 Apr 25, In : BMC Cancer. 18, 1, 466.

    Research output: Contribution to journalArticle

  6. 2017
  7. Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

    Rosenquist, R., Mansouri, L., Bhoi, S., Castellano, G., Sutton, L. A., Papakonstantinou, N., Queirós, A., Baliakas, P., Ek, S., Kuci Emruli, V., Plevova, K., Ntoufa, S., Davis, Z., Young, E., Goransson-Kultima, H., Isaksson, A., Smedby, K. E., Gaidano, G., Langerak, A. W., Davi, F. & 7 othersRossi, D., Oscier, D., Pospisilova, S., Ghia, P., Campo, E., Stamatopoulos, K. & Subero, I. M., 2017, In : Blood. 130, Suppl 1, p. 57-57 1 p.

    Research output: Contribution to journalPublished meeting abstract

  8. 2016
  9. A Molecular Dissection of Mantle Cell Lymphoma - From gene expression analysis to functional evaluation of selected targets

    Venera Kuci, 2016, Department of Immunotechnology, Lund University.

    Research output: ThesisDoctoral Thesis (compilation)

  10. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.

    Venera Kuci, Nordström, L., Conrotto, P. & Sara Ek, 2016, In : Leukemia & Lymphoma.

    Research output: Contribution to journalArticle

  11. 2015
  12. Emerging role of SOX11 in mantle cell lymphoma

    Venera Kuci, Nordström, L., Mats Jerkeman & Sara Ek, 2015, In : Blood and Lymphatic Cancer: Targets and Therapy. 5, p. 35-41

    Research output: Contribution to journalReview article

  13. 2011
  14. Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo

    Conrotto, P., Andreasson, U., Venera Kuci, Carl Borrebaeck & Sara Ek, 2011, In : Molecular Oncology. 5, p. 527-537

    Research output: Contribution to journalArticle